Study Stopped
Due to the COVID-19 Pandemic
Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch
1 other identifier
observational
20
1 country
1
Brief Summary
The purpose of this study to improve methods of monitoring and diagnosing gastrointestinal bleeding via the E4 wristband, a biosensor watch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2019
CompletedFirst Posted
Study publicly available on registry
March 14, 2019
CompletedStudy Start
First participant enrolled
March 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2021
CompletedMay 3, 2023
April 1, 2023
2.3 years
March 12, 2019
April 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heart Rate
Using the wristband, heart rate will be collected at a frequency of 64 Hz.
Up to 1 year
Skin Conductance
Using the wristband, skin conductance will be collected at a frequency of 4 Hz.
Up to 1 year
Study Arms (1)
High-Risk of GI Bleed
Patients that have a high risk of having a gastrointestinal bleed upon admission into the ICU based on their medical history and symptoms. These patients will have a biosensor watch, the E4 wristband, placed on them to monitor their vital signs.
Interventions
A biosensor watch that monitors the patient's heartbeat, heart rate variability, skin conductance, and temperature in order to discover if they are having a GI bleed
Eligibility Criteria
Patients will be selected from the intensive care unit (ICU) in the Milstein Hospital Building at Columbia University.
You may qualify if:
- Patients with a history of gastrointestinal bleeding and/or showing the symptoms of gastrointestinal bleeding.
You may not qualify if:
- Patients who are not showing the symptoms of gastrointestinal bleeding and/or do not have a history of gastrointestinal bleeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Related Publications (1)
Kim BS, Li BT, Engel A, Samra JS, Clarke S, Norton ID, Li AE. Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):467-78. doi: 10.4291/wjgp.v5.i4.467.
PMID: 25400991BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chin Hur, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2019
First Posted
March 14, 2019
Study Start
March 29, 2019
Primary Completion
July 20, 2021
Study Completion
July 20, 2021
Last Updated
May 3, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share with other researchers outside of the research team.